Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Microb Pathog ; 192: 106691, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38759933

RESUMO

Necrotic enteritis (NE) is a potentially fatal poultry disease that causes enormous economic losses in the poultry industry worldwide. The study aimed to evaluate the effects of dietary organic yeast-derived selenium (Se) on immune protection against experimental necrotic enteritis (NE) in commercial broilers. Chickens were fed basal diets supplemented with different Se levels (0.25, 0.50, and 1.00 Se mg/kg). To induce NE, Clostridium perfringens (C. perfringens) was orally administered at 14 days of age post hatch. The results showed that birds fed 0.25 Se mg/kg exhibited significantly increased body weight gain compared with the non-supplemented/infected birds. There were no significant differences in gut lesions between the Se-supplemented groups and the non-supplemented group. The antibody levels against α-toxin and NetB toxin increased with the increase between 0.25 Se mg/kg and 0.50 Se mg/kg. In the jejunal scrapings and spleen, the Se-supplementation groups up-regulated the transcripts for pro-inflammatory cytokines IL-1ß, IL-6, IL-8, iNOS, and LITAF and avian ß-defensin 6, 8, and 13 (AvBD6, 8 and 13). In conclusion, supplementation with organic yeast-derived Se alleviates the negative consequences and provides beneficial protection against experimental NE.


Assuntos
Ração Animal , Galinhas , Infecções por Clostridium , Clostridium perfringens , Citocinas , Suplementos Nutricionais , Enterite , Doenças das Aves Domésticas , Selênio , Animais , Enterite/prevenção & controle , Enterite/veterinária , Enterite/imunologia , Enterite/microbiologia , Selênio/farmacologia , Selênio/administração & dosagem , Doenças das Aves Domésticas/prevenção & controle , Doenças das Aves Domésticas/imunologia , Clostridium perfringens/imunologia , Infecções por Clostridium/prevenção & controle , Infecções por Clostridium/veterinária , Infecções por Clostridium/imunologia , Citocinas/metabolismo , Toxinas Bacterianas/imunologia , Necrose , beta-Defensinas/metabolismo , Jejuno/efeitos dos fármacos , Jejuno/imunologia , Jejuno/microbiologia , Jejuno/patologia , Baço/imunologia , Leveduras , Óxido Nítrico Sintase Tipo II/metabolismo , Interleucina-6/metabolismo , Interleucina-8/metabolismo , Interleucina-1beta/metabolismo , Anticorpos Antibacterianos/sangue
2.
Adv Sci (Weinh) ; 11(4): e2306044, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38032137

RESUMO

The assembly line biosynthesis of the powerful anticancer-antiviral didemnin cyclic peptides is proposed to follow a prodrug release mechanism in Tristella bacteria. This strategy commences with the formation of N-terminal prodrug scaffolds and culminates in their cleavage during the cellular export of the mature products. In this study, a comprehensive exploration of the genetic and biochemical aspects of the enzymes responsible for both the assembly and cleavage of the acylated peptide prodrug scaffolds is provided. This process involves the assembly of N-acyl-polyglutamine moieties orchestrated by the nonribosomal peptide synthetase DidA and the cleavage of these components at the post-assembly stage by DidK, a transmembrane CAAX hydrolase homolog. The findings not only shed light on the complex prodrug mechanism that underlies the synthesis and secretion of didemnin compounds but also offer novel insights into the expanded role of CAAX hydrolases in microbes. Furthermore, this knowledge can be leveraged for the strategic design of genome mining approaches aimed at discovering new bioactive natural products that employ similar prodrug biochemical strategies.


Assuntos
Depsipeptídeos , Pró-Fármacos , Peptídeo Hidrolases , Endopeptidases , Pró-Fármacos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA